Antipsychotic drugs and venous thromboembolism

Thrombosis Research

Volumn 130, Issue SUPPL.1, 2012, Pages

  Tromeur, Cécile ^a   Couturaud, Francis ^a  

^a Universite de Brest   (France)

Author keywords

Antipsychotics; Neuroleptics; Venous thromboembolism

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARDIOLIPIN ANTIBODY; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SERTINDOLE; ZUCLOPENTHIXOL;

ARTICLE; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; ANTIPSYCHOTIC AGENTS; FIBRINOLYTIC AGENTS; HUMANS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84866984138     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.08.267     Document Type: Article

References (37)

1. E. Oger Incidence of venous thromboembolism: a community based study in Western France. EPI-GETBO Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale Thromb Haemost 83 2000 657 660
2. F.R. Rosendaal Venous thrombosis: a multicausal disease Lancet 353 1999 1167 1173
3. K. Meier-Ewert, H.H. Baumgart, and P. Friedenberg Thromboembolische komplikationen bei neuro- und thymoleptisher behandlung Dtsch Med Wochenschr 47 1967 2174 2178
4. I. Varia, R.R. Krishnan, and J. Davidson Deep vein thrombosis with antipsychotic drugs Psychosomatics 24 1983 1097 1098
5. M. Thorogood, P. Cowen, J. Manna, M. Murphy, and M. Vessey Fatal myocardial infarction and use of psychotropic drugs in young women Lancet 340 1992 1067 1068
6. J. Pantel, J. Schroder, K. Eysenbach, and C. Mundt Two cases of deep vein thrombosis associated with a combined paroxetine and zotepine therapy Pharmacopsychiatry 30 1997 109 111
7. R. Thomassen, J.P. Vandenbrouke, and F.R. Rosendaal Antipsychotic drugs and venous thromboembolism Lancet 365 2000 252
8. S. Hägg, and O. Spigset Antipsychotic-induced venous tromboembolism: a review of the evidence CNS Drugs 16 2002 765 776
9. G.I. Zornberg, and H. Jick Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case control study Lancet 356 2000 1219 1223
10. R. Liperoti, C. Pedone, and K.L. Lapane Venous thromboembolism among eldery patients treated with atypical and conventional antipsychotic agents Arch Intern Med 165 2005 2677 2682
11. K. Lacut, G. Le Gal, F. Couturaud, G. Cornily, C. Leroyer, and D. Mottier Association between antipsychotic drugs, antidepressant drugs and venous thrmoboembolism: results from the EDITH case-control study Fundam Clin Pharmacol 21 2007 643 650
12. A.K. Jönsson, L. Brudin, J. Ahlner, K. Hedenmalm, A. Ericsson, and S. Hägg Antipsychotics associated with pulmonary embolism in a Swedish medicolegal autopsy series Int Clin Psychopharmacol 23 2008 263 268
13. A.K. Jönsson, E. Horváth-Puhó, S. Hägg, L. Pedersen, and H.T. Sorensen Antipsychotics and risk of venous thromboembolism: A population based case-control study Clin Epidemiol 1 2009 19 26
14. Y. Kamijo, K. Soma, T. Nagai, K. Kurihara, and T. Ohwada Acute massive pulmonary thromboembolism associated with risperidone and convetional phenothiazines Circ J 67 2003 46 48
15. I.M. Waage, and A. Gedde-Dahl Pulmonary embolism possibly associated with olanzapine treatment BMJ 327 2003 384
16. S. Hägg, P. Tatting, and O. Spigset Olanzapine and venous thromboembolism Int Clin Psychopharmacol 18 2003 299 300
17. L. Borras, A. Eytan, P. de Timary, E.L. Constant, P. Huguelet, and C. Hermans Pulmonary thromboembolism associated with olanzapine and risperidone J Emerg Med 35 2007 159 161
18. R. MalyÍ, J. Masopust, L. Hosák, and A. Urban Four cases of venous thromboembolism associated with olanzapine Psychiatry Clin Neurosci 63 2009 116 118
19. J.G. Ray, M.M. Mamdani, and E.L. Yeo Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism Thromb Haemost 88 2002 205 209
20. L. Parkin, D.C. Skegg, G.P. Herbison, and C. Paul Psychotic drugs and fatal pulmonary embolism Pharmacoepidemiol Drug Saf 12 2003 647 652
21. S. Hägg, A.K. Jönsson, and O. Spigset Risk of venous thromboembolism due to antipsychotic drug therapy Expert Opin Drug Saf 8 2009 537 547
22. M. Joukamaa, M. Heliövaara, P. Knekt, A. Aromaa, R. Raitasalo, and V. Lehtinen Schizophrenia, neuroleptic medication and mortality Br J Psychiatry 188 2006 122 127
23. D.P. Osborn, C.A. Wright, G. Levy, M.B. King, R. Deo, and I. Nazareth Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis BMC Psychiatry 8 2008 84
24. D.J. Boullin, H.F. Woods, R.P. Grimes, and D.G. Grahame-smith Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chorpromazine Br J Clin Pharmacol 2 1975 29 35
25. M.W. Orr, and D.J. Boullin The relationship between changes in 5-HT induced platelet aggregation and clinical state in patients treated with fluphenazine Br J Clin Pharmacol 3 1976 925 928
26. H. Wallaschofski, M. Eigenthaler, and M. Kiefer Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study J Clin Psychopharmacol 23 2003 479 483
27. R.T. Canoso, R.M. De Oliveira, and R.A. Nixon Neuroleptic-associated autoantibodies. A prevalence study Biol Psychiatry 27 1990 863 870
28. S. Davis, H.B. Kern, and R. Asokan Antiphospholipid antibodies associated with clozapine treatment Am J Hematol 46 1994 166 167
29. R.T. Canoso, and R.M. de Oliveira Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis Am J Hematol 27 1988 272 275
30. E. Susser, A.S. Brown, E. Klonowski, R.H. Allen, and J. Lindenbaum Schizophrenia and impaired homocysteine metabolism: a possible association Biol Psychiatry 44 1998 141 143
31. J. Applebaum, H. Shimon, B.A. Sela, R.H. Belmaker, and J. Levine Homocysteine levels in newly admitted schizophrenic patients J Psychiatr Res 38 2004 413 416
32. M.T. Walsh, M. Ryan, A. Hillmann, R. Condren, D. Kenny, and T. Dinan Elevated expression of integrin alpha(IIb) beta(IIIa) in drug-naïve, first episode schizophrenic patients Biol Psychiatry 52 2002 874 879
33. J. Masopust, R. MalyÍ, C. AndryÍs, M. Vališ, J. Bažant, and L. Hosák Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study BMC Psychiatry 11 2011 2
34. S. Hagg, A. Bate, M. Stahl, and O. Spigset Associations Between Venous Thromboembolism and Antipsychotics. A Study of the WHO Database of Adverse Drug Reactions Drug Saf 31 2008 685 694
35. R. Zhang, L. Dong, F. Shao, X. Tan, and K. Ying Antipsychotics and venous thromboembolism risk: a meta-analysis Pharmacopsychiatry 44 5 2011 Jul 183 188 [Epub 2011 Jul 7]
36. M.M. Samama, A.T. Cohen, and J.Y. Darmon for the Prophylaxis in Medical Patients with Enoxaparin Study Group. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients N Engl J Med 11 1999 793 800
37. C. Kearon, E.A. Akl, A.J. Comerota, P. Prandoni, P. Bounameaux, and S.Z. Goldhaber Antithrombotic Therapy for VTE Disease. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians. Evidence-Based Clinical Practice Guidelines Chest 141 2012 e419S e494S